Tudor Investment Corporation »

Alnylam Pharmaceuticals shares owned by Tudor Investment Corporation

Quarter-by-quarter ownership of Alnylam Pharmaceuticals (ALNY) shares owned by Tudor Investment Corporation from 13F filings

Historical chart of Tudor Investment Corporation investment in Alnylam Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Alnylam Pharmaceuticals held by Tudor Investment Corporation consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Alnylam Pharmaceuticals by Tudor Investment Corporation

Quarter filed Position value Share count Share price at filing
2010-12-31 $219k 22k 9.86
2006-03-31 $4.0M 225k 17.59

More positions owned by Tudor Investment Corporation

Ishares Russell 2000 Etf - US ETP ETF Option Call Option (IWM)
Invesco Qqq Trust Series 1 - US ETP ETF Option Call Option (QQQ)
Spdr S&P 500 Etf Trust - US ETP ETF Option Call Option (SPY)
Energy Select Sector Spdr Fund - US ETP ETF Option Call Option (XLE)
Ishares China Large-Cap Etf - US ETP ETF Option Call Option (FXI)
Nvidia Corp - US Equity (NVDA)
Ishares Msci Emerging Markets Etf - US ETP ETF Option Call Option (EEM)
Unitedhealth Group Inc - US Equity (UNH)
Utilities Select Sector Spdr Fund - US ETP ETF Option Call Option (XLU)
Financial Select Sector Spdr Fund - US ETP ETF Option Call Option (XLF)
Palantir Technologies Inc - US Equity (PLTR)
Oracle Corp - US Equity Option Call Option (ORCL)
Micron Technology Inc - US Equity (MU)
Goldman Sachs Group Inc/The - US Equity Option Call Option (GS)
Apple Inc - US Equity (AAPL)

View all positions for Tudor Investment Corporation

Top funds holding Alnylam Pharmaceuticals

FMR
Capital World Investors
Vanguard Group
BlackRock
Capital Research Global Investors
Jpmorgan Chase & Co
Groupama Asset Managment
State Street Corporation
Baillie Gifford & Co
Geode Capital Management
Dodge & Cox
T. Rowe Price Investment Management
Orbis Allan Gray
Wellington Management Company
Susquehanna International

View all funds holding Alnylam Pharmaceuticals